Cleared Abbreviated

K061616 - COULTER LH 780 HEMATOLOGY ANALYZER

K061616 is the FDA 510(k) clearance for COULTER LH 780 HEMATOLOGY ANALYZER by Beckman Coulter, Inc.. It is a Class 2 Hematology device (product code GKZ) cleared through the Abbreviated 510(k) pathway after a 118-day FDA review.

K061616 · Beckman Coulter, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2006
Decision
118d
Days
Class 2
Risk

K061616 is an FDA 510(k) clearance for the COULTER LH 780 HEMATOLOGY ANALYZER. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Beckman Coulter, Inc. (Miami, US). The FDA issued a Cleared decision on October 4, 2006 after a review of 118 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Beckman Coulter, Inc. devices

Submission Details

510(k) Number K061616 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 08, 2006
Decision Date October 04, 2006
Days to Decision 118 days
Submission Type Abbreviated
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
5d slower than avg
Panel avg: 113d · This submission: 118d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 193
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K061616.
FLOWCARE TLG REAGENT
K081526 · Beckman Coulter, Inc. · Aug 2008
CYTOMICS FC 500 MPL FLOW CYTOMETER, MODEL # 626554
K071681 · Beckman Coulter, Inc. · Oct 2007
BC-3200 AUTO HEMATOLOGY ANALYZER
K063407 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jun 2007
COULTER LH 750 HEMATOLOGY ANALYZER, MODEL 6605632
K061574 · Beckman Coulter, Inc. · Jul 2006
CELL-DYN RUBY SYSTEM
K061667 · Abbott Laboratories · Jul 2006
MODIFICATION TO COULTER LH 750 HEMATOLOGY ANALYZER
K052905 · Beckman Coulter, Inc. · Nov 2005